Lista de obras -

AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins

artículo científico publicado en 2017

Action of hexachlorobenzene on tumor growth and metastasis in different experimental models

artículo científico publicado en 2013

Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression

artículo científico publicado en 2015

Antiprogestins in breast cancer treatment: are we ready? ⬇️

artículo científico publicado el 3 de mayo de 2012

Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice

artículo científico publicado en 2005

Associated expressions of FGFR-2 and FGFR-3: from mouse mammary gland physiology to human breast cancer

artículo científico publicado en 2011

Association of estrogen receptor-alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment

artículo científico publicado en 2007

Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis.

artículo científico publicado en 2008

Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effects.

artículo científico publicado en 2010

Cytogenetic characterization of the murine bladder cancer model MB49 and the derived invasive line MB49-I.

artículo científico publicado en 2012

Cytogenetic findings, Trp53 mutations, and hormone responsiveness in a medroxyprogesterone acetate induced murine breast cancer model

artículo científico publicado en 2005

Differential effects of raloxifene, tamoxifen and fulvestrant on a murine mammary carcinoma

artículo científico publicado en 2003

Enhanced antitumor immunity via endocrine therapy prevents mammary tumor relapse and increases immune checkpoint blockade sensitivity

scientific article published on 02 December 2020

Establishment of two hormone-responsive mouse mammary carcinoma cell lines derived from a metastatic mammary tumor

artículo científico publicado en 2004

Estrogen or antiprogestin treatment induces complete regression of pulmonary and axillary metastases in an experimental model of breast cancer progression

artículo científico publicado en 2005

Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters

scientific journal article

Evidence for two progesterone receptor binding sites in murine mammary carcinomas

artículo científico publicado en 2003

Extra nuclear localization of steroid receptors and non genomic activation mechanisms

artículo científico publicado en 2010

FGFR3 Down-Regulation is Involved in bacillus Calmette-Guérin Induced Bladder Tumor Growth Inhibition

artículo científico publicado en 2015

Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas.

artículo científico publicado en 2010

Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta?

artículo científico publicado en 2009

Inoculated mammary carcinoma-associated fibroblasts: contribution to hormone independent tumor growth

artículo científico publicado en 2010

Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer.

artículo científico publicado en 2011

Involvement of matrix metalloproteinase activity in hormone-induced mammary tumor regression

artículo científico publicado en 2006

Isoform specificity of progesterone receptor antibodies

artículo científico publicado en 2017

Isolation of a stromal cell line from an early passage of a mouse mammary tumor line: a model for stromal parenchymal interactions.

artículo científico publicado en 2005

MPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with different hormonal requirements.

artículo científico publicado en 2010

Mifepristone inhibits MPA-and FGF2-induced mammary tumor growth but not FGF2-induced mammary hyperplasia

artículo científico publicado el 1 de enero de 2010

NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis

artículo científico publicado en 2008

Novel human breast cancer cell lines IBH-4, IBH-6, and IBH-7 growing in nude mice.

artículo científico publicado en 2009

Novel, low cost, highly effective, handmade steroid pellets for experimental studies

artículo científico publicado en 2013

Nuclear staining of fgfr-2/stat-5 and runx-2 in mucinous breast cancer

artículo científico publicado en 2015

PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer

artículo científico publicado en 2011

Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.

artículo científico publicado en 2017

Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment

artículo científico publicado en 2003

Progesterone receptors--animal models and cell signalling in breast cancer. Diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancer

artículo científico publicado en 2002

Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.

artículo científico publicado en 2014

Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors

artículo científico publicado el 1 de enero de 1997

Responsiveness to PI3K and MEK inhibitors in breast cancer. Use of a 3D culture system to study pathways related to hormone independence in mice

artículo científico publicado en 2010

Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas

artículo científico publicado en 2008

Targeting progesterone receptors in breast cancer.

artículo científico

The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer.

scientific article published on 03 February 2009

The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer

artículo científico publicado en 2014

p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas.

artículo científico publicado en 2002

α(2)-Adrenoceptors enhance cell proliferation and mammary tumor growth acting through both the stroma and the tumor cells.

artículo científico publicado en 2011

Lista de obras de

AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins

Action of hexachlorobenzene on tumor growth and metastasis in different experimental models

Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression

Antiprogestins in breast cancer treatment: are we ready? ⬇️

Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice

Associated expressions of FGFR-2 and FGFR-3: from mouse mammary gland physiology to human breast cancer

Association of estrogen receptor-alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment

Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis.

Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effects.

Cytogenetic characterization of the murine bladder cancer model MB49 and the derived invasive line MB49-I.

Cytogenetic findings, Trp53 mutations, and hormone responsiveness in a medroxyprogesterone acetate induced murine breast cancer model

Differential effects of raloxifene, tamoxifen and fulvestrant on a murine mammary carcinoma

Enhanced antitumor immunity via endocrine therapy prevents mammary tumor relapse and increases immune checkpoint blockade sensitivity

Establishment of two hormone-responsive mouse mammary carcinoma cell lines derived from a metastatic mammary tumor

Estrogen or antiprogestin treatment induces complete regression of pulmonary and axillary metastases in an experimental model of breast cancer progression

Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters

Evidence for two progesterone receptor binding sites in murine mammary carcinomas

Extra nuclear localization of steroid receptors and non genomic activation mechanisms

FGFR3 Down-Regulation is Involved in bacillus Calmette-Guérin Induced Bladder Tumor Growth Inhibition

Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas.

Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta?

Inoculated mammary carcinoma-associated fibroblasts: contribution to hormone independent tumor growth

Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer.

Involvement of matrix metalloproteinase activity in hormone-induced mammary tumor regression

Isoform specificity of progesterone receptor antibodies

Isolation of a stromal cell line from an early passage of a mouse mammary tumor line: a model for stromal parenchymal interactions.

MPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with different hormonal requirements.

Mifepristone inhibits MPA-and FGF2-induced mammary tumor growth but not FGF2-induced mammary hyperplasia

NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis

Novel human breast cancer cell lines IBH-4, IBH-6, and IBH-7 growing in nude mice.

Novel, low cost, highly effective, handmade steroid pellets for experimental studies

Nuclear staining of fgfr-2/stat-5 and runx-2 in mucinous breast cancer

PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer

Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.

Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment

Progesterone receptors--animal models and cell signalling in breast cancer. Diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancer

Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.

Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors

Responsiveness to PI3K and MEK inhibitors in breast cancer. Use of a 3D culture system to study pathways related to hormone independence in mice

Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas

Targeting progesterone receptors in breast cancer.

The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer.

The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer

p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas.

α(2)-Adrenoceptors enhance cell proliferation and mammary tumor growth acting through both the stroma and the tumor cells.